Showing results (61-70 of 83) with videos related to
Sort By:
Pageof 9
Menopause (New York, N.Y.)|January 17, 2007
Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal womenDeborah Grady, Eric Vittinghoff, Feng Lin, et al.Circulation. Cardiovascular Quality and Outcomes|March 14, 2013
Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) TrialLori B Daniels, Deborah Grady, Lori Mosca, et al.Obstetrics and Gynecology|December 7, 2002
Menopausal symptoms in older women and the effects of treatment with hormone therapyVanessa M Barnabei, Deborah Grady, Dale W Stovall, et al.Annals of Internal Medicine|May 17, 2006
The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinenceJeanette S Brown, Catherine S Bradley, Leslee L Subak, et al.Fertility and Sterility|December 15, 2015
PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroidsVanessa L Jacoby, Maureen P Kohi, Liina Poder, et al.Menopause (New York, N.Y.)|February 3, 2009
MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trialDeborah Grady, George F Sawaya, Karen C Johnson, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 26, 2007
Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart TrialKristine E Ensrud, John L Stock, Elizabeth Barrett-Connor, et al.The American Journal of Cardiology|November 27, 2002
Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trialNanette Kass Wenger, Elizabeth Barrett-Connor, Peter Collins, et al.Journal of the National Cancer Institute|June 12, 2008
Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary riskDeborah Grady, Jane A Cauley, Mary Jane Geiger, et al.JAMA|July 2, 2002
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)Stephen Hulley, Curt Furberg, Elizabeth Barrett-Connor, et al.Pageof 9